Ipca Laboratories Limited (NSE: IPCALAB) reported Revenue from Operations for Q3 FY23 of ₹1,546 Crore up from ₹1,430.47 Crore year on year, a growth of 8%. The Consolidated Net Profit of ₹107.84 Crore, down 45% from ₹196.96 Crore in the same quarter of the previous year. The Earnings per Share is ₹4.25 for this quarter.
Ipca Laboratories Limited Q3 FY23; Revenue Increased To ₹1,546 Crore
Tags: pharmaceuticals
Related Post
- Syngene Q3 FY26 Earnings Results
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO)…
-
Grindwell Norton Q2 FY26 Earnings Results
Grindwell Norton Limited, engaged in manufacturing abrasives, ceramics & plastics and providing IT services, reported…
-
H.G. Infra Q2 FY26 Earnings Results
H.G. Infra Engineering Limited (HGIEL), an Indian road infrastructure company engaged in EPC services, maintenance…